Cart
sales@molnova.com
RGD (Arg-Gly-Asp) Peptides
CAS No. 99896-85-2
RGD (Arg-Gly-Asp) Peptides( Arg-Gly-Asp | Arg Gly Asp | RGD )
Catalog No. M16919 CAS No. 99896-85-2
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 51 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 147 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 406 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRGD (Arg-Gly-Asp) Peptides
-
NoteResearch use only, not for human use.
-
Brief DescriptionRGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
-
DescriptionRGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
-
In VitroRGD is the most effective and most often employed peptide sequence for stimulated cell adhesion on synthetic surfaces. There are 24 integrins binding to ECM molecules in a RGD dependent manner: α3β1, α5β1, α8β1, αIIbβ3, αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, and to some extent α2β1 and α4β1.
-
In Vivo——
-
SynonymsArg-Gly-Asp | Arg Gly Asp | RGD
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number99896-85-2
-
Formula Weight346.34
-
Molecular FormulaC??H??N?O?
-
Purity>98% (HPLC)
-
SolubilityDMSO:<1 mg/mL;Ethanol:<1 mg/mL;Water:10 mg/mL (28.9 mM)
-
SMILESO=C(O)C[C@@H](C(O)=O)NC(CNC([C@H](CCCNC(N)=N)N)=O)=O
-
Chemical NameArginylglycylaspartic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hersel U, et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003 Nov;24(24):4385-415.
molnova catalog
related products
-
GSK-3008348
GSK-3008348 is a novel potent, selective integrin αvβ6 antagonist for the treatment of idiopathic pulmonary fibrosis (IPF).
-
Firategrast
Firategrast (SB 683699) is an orally active and specific α4β1/α4β7 integrin antagonist that reduces the transport of lymphocytes into the central nervous system (CNS) and decreases multiple sclerosis (MS) activity.
-
Bexotegrast
Bexotegrast (PLN-74809) is an orally active and potent inhibitor of αvβ6 and αvβ1 integrins with antifibrotic effects, inhibiting αvβ6 and αvβ1-induced activation of TGF-β.
